{"url_path":"/sec/aaql/10-k/2026/item-12","section_key":"item-12","section_title":"Item 12 Security ownership of certain beneficial owners and management**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-07-14","source_url":"https://www.sec.gov/Archives/edgar/data/1672571/0001493152-26-033212-index.html","accession_number":"0001493152-26-033212","cik":"0001672571","ticker":"AAQL","issuer_name":"Antiaging Quantum Living Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1672571/0001493152-26-033212-index.html","primary_entity_key":"0001672571","primary_entity_name":"Antiaging Quantum Living Inc."},"word_count":417,"has_tables":true,"body_markdown":"**Item\n12. Security ownership of certain beneficial owners and management**\n\n \n\nThe\nfollowing table sets forth, as of March 31, 2026, the number and percentage of outstanding shares of Class A Common Stock beneficially\nowned by: (i) each person known by the Company to beneficially own more than 5% of the Company’s outstanding Class A Common Stock;\n(ii) each director; (iii) each named executive officer; and (iv) all directors and executive officers as a group.\n\n \n\nBeneficial\nownership is determined in accordance with the rules of the Securities and Exchange Commission. The percentage ownership set forth below\nis based on 34,275,340 shares of Class A Common Stock issued and outstanding as of March 31, 2026. Unless otherwise indicated, the\nprincipal address of each stockholder listed below is c/o Antiaging Quantum Living Inc., 135-27 38th Avenue, #388, Flushing, New York\n11354.\n\n \n\nTitle\nof Class \n\n**Name\nand Address**\n\n**Of\nBeneficial Owner**\n \nPosition  \n\n**Amount\nand Nature**\n\n**Of\nBeneficial Ownership**\n  \n\n**Percent**\n\n**Of\nClass(1)**\n \n\n  \n  \n   \n   \n  \n\nClass A Common Stock \n\nNew\nLite Ventures LLC\n\nA.K.A\nNew Living Ventures LLC,\n\n135-27\n38th Ave #388\n\nFlushing,\nNY 11354 (2)(3)\n \n -  \n 29,215,000  \n 85.24%\n\nClass A Common Stock \nBarry Wan, 135-27 38th Avenue, #388, Flushing,\nNY 11354 \n \nChief\n\nExecutive\nOfficer, Chief Financial Officer, Treasurer, Secretary, and Chairman of the Board\n  \n 29,215,000  \n 85.24%\n\nClass A Common Stock \nAtlantic Equity Holdings Inc., 8 The Green,\nSte R, Dover, DE 19901 \n    \n 1,893,796  \n 5.53%\n\nClass A Common Stock \nEmpire Street Capital Inc., 136-20 38th Avenue,\nSte 3D, Flushing, NY 11354 Empire Street Capital Inc., 136-20 38th Avenue, Ste 3D, Flushing, NY 11354 \n    \n 2,386,544  \n 6.96%\n\nClass A Common Stock \nAll directors and executive officers as a group,\none person \n    \n 29,215,000  \n 85.24%\n\n \n\n(1)\nBased on 34,275,340 shares of Class A Common Stock issued and outstanding as of March 31, 2026.\n\n \n\n(2)\nMr. Barry Wan may be deemed to beneficially own the shares held by New Lite Ventures LLC, also known as New Living Ventures LLC, because\nhe wholly owns and controls New Lite Ventures LLC. The shares reported for Mr. Wan and for all directors and executive officers as a\ngroup consist of the same shares held of record by New Lite Ventures LLC and should not be double-counted.\n\n \n\n(3)\nIncludes 1,893,796 shares issued to Atlantic Equity Holdings Inc. upon conversion of the notes originally issued to New Lite Ventures\nLLC and Antiaging Doctor Hangzhou Holding Ltd.\n\n \n\n(4)\nIncludes 2,386,544 shares issued to Empire Street Capital Inc. upon conversion of the notes originally issued to Barry Wan and Dao Ling\nDoctor (Zhejiang) Health Management Limited.\n\n \n\n17"}